The present pilot study investigates the feasibility of a prospective larger confirmatory study on the efficacy of Dr. Hauschka Med Ice Plant Intensive Cream for the prevention of hand-foot syndrome in patients with breast carcinoma undergoing therapy with doxorubicin and / or docetaxel.
Age range
18 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Number of patients that can be recruited in a 9 months time period
Timeframe: 7 days after last chemotherapy cycle (each cycle is 3-4 weeks)
Proportion of potentially eligible patients that agree to participate in the study and thus to randomization
Timeframe: 7 days after last chemotherapy cycle (each cycle 3-4 weeks )
Proportion of randomized patients who leave the study early
Timeframe: 7 days after last chemotherapy cycle (each cycle is 3-4 weeks)
Number of days in which the symptom diary was completed correctly
Timeframe: 7 days after last chemotherapy cycle (each cycle is 3-4 weeks)
Number of days in which the intervention was carried out per protocol
Timeframe: 7 days after last chemotherapy cycle (each cycle is 3-4 weeks)